Catalyst Biosciences, Inc CBIO

mauretto432

CBIO = my return will focus only on a few stocks to keep .. minimum 5 days max 1 month ... MARKETS SHOW PANIC IS THE PERFECT TIME TO INVEST IN CONTRARIAN PHARMACEUTICAL ... This company has También noté in the super column green an incremental increase de volumen, que puede haber sido verificado ... in the triangles of the previous movements, mi punto es que el...

DigitalData

All, I think CBIO is a good play down here maybe wait and see for the break, but overall should be an easy pop. Also end of 2021 or before first dosed patient results. Combination would be deadly at least a 30%er if positive. Low enough float to play with TA alone though.

runNgun Premium

this one has amazing potential for the long term had a nice run with this one last week for 50% profits. kept a small core position that i will be adding to for long

boreyyy

If it stays tight around the $6.0-6.8 range until March we will see a break either up or down and I possibly will ride the wave.

UnknownUnicorn4330292

Beta-R:Journal. Risk Management: Compound .Level : PA . Time: Short-term - Intermediate . This is just my view follow if it aligns with yours. Ideas are not repeated rather updated.Worry about risk only.

EcoTrader-tv Pro

Hi, today we are going to talk about Catalyst Biosciences and its current landscape. Catalyst Biosciences is poised to receive increasing attention from the market as relevant events are taking place. The clinical-stage biopharmaceutical company has been soaring over the announcement that the company entered into a global science collaboration agreement with...

AC-TRADER Pro+

Uptick in volume and relatively clean sky above 200 SMA

PennyStock101 Premium

CATALYST BIOSCIENCES INC CBOE ($CBIO) CBIO will release at the ISTH conference final Phase 2 data for marzeptaacog alfa in hemophilia.Dr. Johnny Mahlangu, M.D., Professor of haematology, faculty of health sciences, head of the School of Pathology at the University of Witwatersrand in Johannesburg, South Africa, and a principal investigator on the MarzAA Phase 2...

theonetheonly310

weekly chart wilder ma

meitshel Premium

short term target on chart see some MOMO until FDA news coming out 07/18/2018 Phase 2 commencement of Part 2 of Phase 2/3 trial announced January 4, 2018. Interim data due at ISTH July 18, 2018. Final data due at ASH 2018. potential gapper candidate

wolfstreetswinger

cbio has been popping up multiple times on my scans playing around in my action zone between the 10ma and 30ema with 5 consecutive down days + nr7 inside day on low volume. Looks to be holding those supports quite well, triangulating and Volume has been drying up nicely. I would normally like to get in just above that inside days high but with current market...

swish30

Waiting for a spike to trade if good trial data comes out.

AcornWealthCorp Premium

CBIO seems forming a very nice fallen angel formation. It has history of sharp breakout, and at this time it seems getting ready for another breakout. We are looking for a quick day trade if it breaks above $4.70 * Trade Criteria * Date First Found- June 29, 2017 Pattern/Why- Fallen angel formation Entry Target Criteria- Break of $4.70 Exit Target Criteria-...

xvingen

U.S. Government Required Disclaimer - Commodity Futures Trading Commission Futures, Stocks and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation...

StockGuild

$CBIO Recent Highlights and Upcoming Milestones Recent Highlights: Catalyst Biosciences’ Factor IX Recommended for Orphan Drug Designation in Europe Contract revenue for the three months ended March 31, 2017 was $0.3 million, compared with $0.1 million for the prior year period. The increase in contract revenue was due to the milestone revenue from ISU Abxis...

DanielAnt

expec tlong or bi g gap up

DanielAnt

expect long this stock for april, then drop from higher?? might be. anyway i expect a 200% return at least. if more might be my jackpot :D small stop

Anbat

Why did CBIO stock shares practically triple? On longer charts,stock worth over $3,000 share once. Catalyst Biosciences Inc. (CBIO) saw its shares practically triple in Tuesday’s session after the company announced a critical regulatory approval. The company reported that the Korean Ministry of Food and Drug Safety (MFDS) approved the Investigational New Drug...